HOME > ARCHIVE
ARCHIVE
- Anti-epileptic Zonisamide to Be Effective against Parkinson's Disease
May 28, 2001
- Teijin: Pharmaceutical Sales Up 1.6% to \88.6 Bil.
May 28, 2001
- None of the Current Proposals Stabilizes Health Insurance Finance: Kenporen Simulation
May 28, 2001
- Seijo: Sales Up 15%, Operating Profits Down 3%
May 28, 2001
- Kobayashi Pharmaceutical: Record-high Sales, Profits
May 28, 2001
- REGULATORY NEWS IN BRIEF
May 28, 2001
- PAJ's Council on Self-medication Promotion to Start Discussions in June
May 28, 2001
- Long-Term Incentives Are Essential to Develop New Drugs: Dr McKinnell
May 28, 2001
- Keidanren, Nikkeiren Propose Senior Healthcare System
May 28, 2001
- JSMBE Advocates IT Revolution in BME
May 28, 2001
- Eisai Reorganizes R&D System to Accelerate Clinical Trials in Japan
May 28, 2001
- Benefits under Government-managed Health Insurance Down 1.7% to \4,207.6 Bil.
May 28, 2001
- Fresenius Completes New CAPD System Plant in Buzen
May 28, 2001
- Securities Analyst Recommends Win-win M&As to Domestic Drug Companies
May 28, 2001
- Yamanouchi to Tie Up with Hitachi for Genomic Drug Discovery
May 28, 2001
- BSJ: New Product in Maverick Series
May 28, 2001
- Takeda, Pharmacia Tie Up for Marketing of OTC NRT Products
May 28, 2001
- International A-II Symposium 2001 Held by Banyu
May 28, 2001
- DIAGNOSTIC NEWS IN BRIEF -1-
May 28, 2001
- Meiji Seika, Solvay to Codevelop Drug for Parkinson's Disease
May 28, 2001
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
